Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.3K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

239
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
239
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

419
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
419
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

137
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
137
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

142
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
142
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

163
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
163

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying and targeting abnormal mitochondrial localization associated with psychosis.

bioRxiv : the preprint server for biology·2026
Same author

Single-cell hit calling in high-content imaging screens with Buscar.

bioRxiv : the preprint server for biology·2026
Same author

Progress and new challenges in image-based profiling.

Molecular systems biology·2026
Same author

A scalable approach to resolving variants of uncertain significance.

bioRxiv : the preprint server for biology·2026
Same author

Counting cells can accurately predict small-molecule bioactivity benchmarks.

Nature communications·2026
Same author

nELISA: a high-throughput, high-plex platform enables quantitative profiling of the inflammatory secretome.

Nature methods·2025

Related Experiment Video

Updated: Oct 2, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Predicting drug polypharmacology from cell morphology readouts using variational autoencoder latent space arithmetic.

Yuen Ler Chow1,2, Shantanu Singh1, Anne E Carpenter1

  • 1Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.

Plos Computational Biology
|February 25, 2022
PubMed
Summary

Variational autoencoders (VAEs) can learn cell morphology and gene expression. Improved VAEs like β-VAE and MMD-VAE create interpretable latent spaces for predicting drug effects and identifying targeted therapeutics.

More Related Videos

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.7K
Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

17.5K

Related Experiment Videos

Last Updated: Oct 2, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.7K
Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

17.5K

Area of Science:

  • Computational biology
  • Machine learning in drug discovery
  • Bioimage analysis

Background:

  • Variational autoencoders (VAEs) generate compressed, interpretable latent spaces from biomedical data.
  • Standard VAEs often have entangled latent spaces, limiting their utility.
  • Specialized VAEs like β-VAE and MMD-VAE offer improved disentanglement and interpretability.

Purpose of the Study:

  • To evaluate the capacity of VAEs to learn cell morphology from images.
  • To assess the generative capabilities of VAE variants (Vanilla, β-VAE, MMD-VAE) in predicting compound polypharmacology.
  • To explore the utility of gene expression data as a complementary information source.

Main Methods:

  • Training and evaluating Vanilla VAE, β-VAE, and MMD-VAE on cell morphology data.
  • Utilizing latent space arithmetic (LSA) to explore generative capacity for predicting polypharmacology.
  • Training VAEs on gene expression data from the same compound perturbations to assess generalizability.

Main Results:

  • β-VAE and MMD-VAE demonstrated superior disentanglement of morphology signals, yielding more interpretable latent spaces.
  • VAE models successfully simulated morphology and gene expression readouts for specific compounds.
  • The models predicted cell states perturbed by compounds with known polypharmacology.

Conclusions:

  • β-VAE and MMD-VAE effectively learn and represent cell morphology and gene expression data.
  • Latent space arithmetic with VAEs can predict compound polypharmacology and infer cell states.
  • This approach can aid in developing targeted therapeutics and understanding drug off-target effects.